ADENOVIRAL VECTOR-BASED MALARIA VACCINES

The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria i...

Full description

Saved in:
Bibliographic Details
Main Authors CARUCCI, DANIEL, JOHN, DOOLAN, DENISE, LOUISE, KING, C., RICHTER, ETTYREDDY, DAMODAR, R, LIMBACH, KEITH, BRUDER, JOSEPH, T, MCVEY, DUNCAN, L, KOVESDI, IMRE
Format Patent
LanguageEnglish
French
Published 08.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria in a mammal comprising administering the adenoviral vectors to the mammal. L'invention concerne des vecteurs adénoviraux constitués d'un génome adénoviral contenant des séquences nucléotidiques codant pour un antigène hétérologue, telles que des séquences nucléotidiques de Plasmodium, liées fonctionnellement à des promoteurs. Cette invention concerne également un procédé pour induire une réponse immunitaire contre la malaria chez un mammifère, qui consiste à administrer ces vecteurs adénoviraux au mammifère.
AbstractList The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium nucleic acid sequences, operably linked to promoters. The invention further provides a method of inducing an immune response against malaria in a mammal comprising administering the adenoviral vectors to the mammal. L'invention concerne des vecteurs adénoviraux constitués d'un génome adénoviral contenant des séquences nucléotidiques codant pour un antigène hétérologue, telles que des séquences nucléotidiques de Plasmodium, liées fonctionnellement à des promoteurs. Cette invention concerne également un procédé pour induire une réponse immunitaire contre la malaria chez un mammifère, qui consiste à administrer ces vecteurs adénoviraux au mammifère.
Author LIMBACH, KEITH
KOVESDI, IMRE
ETTYREDDY, DAMODAR, R
KING, C., RICHTER
CARUCCI, DANIEL, JOHN
BRUDER, JOSEPH, T
DOOLAN, DENISE, LOUISE
MCVEY, DUNCAN, L
Author_xml – fullname: CARUCCI, DANIEL, JOHN
– fullname: DOOLAN, DENISE, LOUISE
– fullname: KING, C., RICHTER
– fullname: ETTYREDDY, DAMODAR, R
– fullname: LIMBACH, KEITH
– fullname: BRUDER, JOSEPH, T
– fullname: MCVEY, DUNCAN, L
– fullname: KOVESDI, IMRE
BookMark eNrjYmDJy89L5WTQcHRx9fMP8wxy9FEIc3UO8Q_SdXIMdnVR8HX0cQzydFQIc3R29vRzDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBuYGRuYWZgaORsbEqQIAfewmpg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate VACCINS CONTRE LA MALARIA A BASE DE VECTEURS ADENOVIRAUX
ExternalDocumentID WO2007027860A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2007027860A23
IEDL.DBID EVB
IngestDate Fri Jul 19 16:02:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2007027860A23
Notes Application Number: WO2006US33982
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070308&DB=EPODOC&CC=WO&NR=2007027860A2
ParticipantIDs epo_espacenet_WO2007027860A2
PublicationCentury 2000
PublicationDate 20070308
PublicationDateYYYYMMDD 2007-03-08
PublicationDate_xml – month: 03
  year: 2007
  text: 20070308
  day: 08
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies GENVEC, INC
LIMBACH, KEITH
KOVESDI, IMRE
ETTYREDDY, DAMODAR, R
KING, C., RICHTER
CARUCCI, DANIEL, JOHN
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY NAVAL MEDICAL RESEARCH CENTER
BRUDER, JOSEPH, T
DOOLAN, DENISE, LOUISE
MCVEY, DUNCAN, L
RelatedCompanies_xml – name: CARUCCI, DANIEL, JOHN
– name: BRUDER, JOSEPH, T
– name: DOOLAN, DENISE, LOUISE
– name: GENVEC, INC
– name: LIMBACH, KEITH
– name: ETTYREDDY, DAMODAR, R
– name: KOVESDI, IMRE
– name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY NAVAL MEDICAL RESEARCH CENTER
– name: MCVEY, DUNCAN, L
– name: KING, C., RICHTER
Score 2.6650705
Snippet The invention provides adenoviral vectors comprising an adenoviral genome comprising heterologous antigen-encoding nucleic acid sequences, such as Plasmodium...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title ADENOVIRAL VECTOR-BASED MALARIA VACCINES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070308&DB=EPODOC&locale=&CC=WO&NR=2007027860A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TCkrxJdgtW9M9DEnTlk3WdtRa9zb6kYIgc7iKf99rt-qe9hYSuCTHfSd3B3Av4xj1cCchOUs0giogJUglkki0NcpGSazbL5OTXU8fvfaeZ_1ZAz7qXJiqTuhPVRwROSpFfi8qeb38D2JZ1d_K1WPyjlOfT044tNTaOy7p11Atc2hPfcsXqhDot6lesF7rMkPXOArsPTSkWeW2RWaZl7LcVirOMexPEd6iOIGGXLTgUNS911pw4G6evHG44b7VKTwg1jw_Ggd8okS2CP2AmPzFthSXT3gw5krEhSi7aJzBnWOHYkRwy_nfDedv_vb56Dk00feXF6BQOpBaHOc6Swe9pMPiLM1oxmieUUlRZl5Cexekq93L13C0DlVSohltaBZf3_IGdWyR3Fao-QVNaXst
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbokYUdYlm8aURKDB4IKbrRkD3QeacvJF9lMTEIJEZ_32vhSlPvDVtcm0v99HftdcDuBNxjH64mZC5kTQIuoCUoJQIIvCsIQslGa2OTE52ve7otf007UxL8FHkwqh_Qn_U54ioUSnqe67s9fI_iGWpt5Wrh-Qduz4fh-HA0gt0LOW3p1vmwJ74ls91zhG36V6wHmsZvW6DocHew0N2T4GlyJR5KcttpzI8gv0J0lvkx1ASiypUeFF7rQoH7ubKG5sb7VudwD1yzfOjccAcLbJ56AfEZC-2pbnMYcGYaRHjXFbROIXboR3yEcEpZ387nL352-ujZ1BG7C_OQaO0LxpxPO8aab-dNI04SzOaGXSeUUHRZtagvovSxe7hG6iMQteZOWPv-RIO12FL-byqDuX861tcob_Nk2vFpl87G34W
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ADENOVIRAL+VECTOR-BASED+MALARIA+VACCINES&rft.inventor=CARUCCI%2C+DANIEL%2C+JOHN&rft.inventor=DOOLAN%2C+DENISE%2C+LOUISE&rft.inventor=KING%2C+C.%2C+RICHTER&rft.inventor=ETTYREDDY%2C+DAMODAR%2C+R&rft.inventor=LIMBACH%2C+KEITH&rft.inventor=BRUDER%2C+JOSEPH%2C+T&rft.inventor=MCVEY%2C+DUNCAN%2C+L&rft.inventor=KOVESDI%2C+IMRE&rft.date=2007-03-08&rft.externalDBID=A2&rft.externalDocID=WO2007027860A2